Stay updated on LY2880070 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.

Latest updates to the LY2880070 in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page has removed several principal investigators and their contact information, which may affect the availability of key personnel for inquiries. Additionally, several dates have been updated, indicating changes in scheduling or timelines.SummaryDifference9%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.8%
- Check16 days agoChange DetectedThe web page has added a new section featuring helpful links related to a phase 1b study of an oral chk1 inhibitor, which may be relevant for users interested in cancer treatment advancements.SummaryDifference1%
- Check23 days agoChange DetectedThe page has undergone significant content removal, including the deletion of detailed study information regarding the safety and efficacy of the drug LY2880070 for various advanced cancers, while some cancer types and a version revision were added.SummaryDifference25%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to include information on Pancreatic Cancer while removing references to Soft Tissue Sarcoma. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.SummaryDifference0.2%
Stay in the know with updates to LY2880070 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.